ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)

Clinical trial NCT02093741 · COMPLETED

Trial details

NCT number: NCT02093741
Sponsor: Baxalta now part of Shire
Status: COMPLETED
Study type: OBSERVATIONAL

Hemophilia A Congenital Factor VIII (FVIII) Deficiency

Start date: 2013-09-20
Primary completion: 2016-01-20
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.